๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase I study of BCNU and intravenous 6-mercaptopurine in patients with anaplastic gliomas

โœ Scribed by David C. Smith; Nicholas A. Vick; Donald L. Trump; Henry S. Friedman; Allan H. Friedman; Joseph Purvis; Al Gauspari; S. Clifford Schold

Publisher
Springer
Year
1992
Tongue
English
Weight
511 KB
Volume
30
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase II study of intravenous 6-thioguan
Phase II study of intravenous 6-thioguanine in patients with advanced carcinoma of the pancreas
โœ Jaffer A. Ajani; Richard Pazdur; Rodger J. Winn; James L. Abbruzzese; Bernard Le ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Springer US ๐ŸŒ English โš– 213 KB

In a phase II study, 32 patients with advanced pancreatic carcinoma were treated with intravenous 6-thioguanine. A 30-min infusion of 55 mg/m ~ (starting dose) was administered once a day for 5 consecutive days, the course being repeated every 5 weeks. A median of two courses (range, 1-10) was admin

A phase I trial of dactinomycin intraven
A phase I trial of dactinomycin intravenous infusion in patients with advanced malignancies
โœ Martin S. Blumenreich; Thomas M. Woodcock; Stephen P. Richman; Mariesa K. Jones; ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 204 KB ๐Ÿ‘ 3 views

Eighteen patients with advanced malignancies refractory to other forms of treatment were given dactinomycin (Act D) as continuous intravenous infusions. Their median age was 51 years (range, 36-67); their median performance status was 50 (range, 40-90) on the Karnofsky scale. Act D was administered